Cases 21 - 30 of 54
Bristol-Myers Squibb Company et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00377
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Lupin Atlantis Holdings, S.A. v. Invagen Pharmaceuticals, Inc.
as 2:2016cv04535
Defendant:
Invagen Pharmaceuticals, Inc.
Plaintiff:
Lupin Atlantis Holdings, S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Lupin Atlantis Holdings S.A. v. InvaGen Pharmaceuticals Inc.
as 1:2016cv00708
Plaintiff:
Lupin Atlantis Holdings S.A.
Defendant:
InvaGen Pharmaceuticals Inc.
Counter_claimant:
InvaGen Pharmaceuticals Inc.
Counter_defendant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. DR. REDDY'S LABORATORIES, LTD. et al
as 3:2016cv02394
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
DR. REDDY'S LABORATORIES, LTD., REDDY'S LABORATORIES, INC., PRINSTON PHARMACEUTICAL INC. and others
Counter_claimant:
PRINSTON PHARMACEUTICAL INC.
Counter_defendant:
BOEHRINGER INGELHEIM CORPORATION , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2016cv00064
Plaintiff:
Bayer Intellectual Property GmbH , Bayer Pharma AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 2:2015cv06919
Counter Claimant:
InvaGen Pharmaceuticals, Inc.
Counter Defendant:
InvaGen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Plaintiff:
UCB Pharma S.A. and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Forest Laboratories LLC et al v. InvaGen Pharmaceuticals Inc.
as 1:2015cv01078
Plaintiff:
Forest Laboratories LLC , Forest Laboratories Holdings Ltd. , Merck KGaA and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca LP et al v. InvaGen Pharmaceuticals Inc.
as 2:2015cv06282
Plaintiff:
AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
AstraZeneca LP et al v. InvaGen Pharmaceuticals Inc.
as 1:2015cv01001
Plaintiff:
AstraZeneca LP , AstraZeneca AB , AstraZeneca UK Limited and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
